Chuck Carignan

Chuck Carignan is an accomplished executive and medical professional with extensive experience in the medical device and biotechnology industries. Currently, Chuck serves as Executive Chair at CAIRDAC and SamanTree Medical SA, while also holding the position of Acting Chief Medical Officer at SURGE Therapeutics and Director at Biothea Pharma Inc. Previous roles include CEO of SoniVie, where Chuck led the development of a novel treatment for renal artery denervation and pulmonary hypertension, and leadership positions at Rex Bionics, BionX Medical Technologies, and NinePoint Medical Inc. Chuck holds a Doctor of Medicine (MD) from Columbia University Vagelos College of Physicians and Surgeons and a Bachelor of Arts (BA) in American Studies from Yale University.